| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 04/01/2004 | US20040063742 Such as 5-(4-Chlorophenyl)-8-methyl-6,7,8,9-tetrahydro-1-H-pyrrolo(3.2-h)isoquinoline-2,3-dione-3-oxime-(phenyl))urea; kits; drug screening |
| 04/01/2004 | US20040063725 Binding neuropeptide Y receptors; hypertension, angina, atherosclerosis, depression, anxiety, inflammation, allergies |
| 04/01/2004 | US20040063717 Employing fatty acid oxidation inhibitor; lowering HbA1c, glucose, total cholesterol and/or triglyceride plasma levels; increasing high density lipoprotein concentration; minimizing side effects; ranolazine |
| 04/01/2004 | US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders |
| 04/01/2004 | US20040063679 Amidino and guanidino peptidyl compounds; autoimmune diseases |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040063643 Bombesin antagonists |
| 04/01/2004 | US20040062706 Reacting selenium with lithium aluminum hydride |
| 04/01/2004 | CA2499490A1 Amide and sulfonamide ligands for the estrogen receptor |
| 04/01/2004 | CA2499213A1 Aromatic liver x-receptor modulators |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | CA2498149A1 3-(3,5-disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors |
| 04/01/2004 | CA2496696A1 Succinic acid semi-amides as anti-corrosive agents |
| 03/31/2004 | EP1403265A1 Industrial process for the synthesis of 5-[bis(carboxymethyl)amino]-3-carboxymethyl-4-cyano-2-thiophene-carboxylic acid tetraesters and use for the synthesis of ranetic acid divalent salts and hydrates thereof |
| 03/31/2004 | EP1403249A1 Cyclic diamine compounds bearing six-membered cyclic groups |
| 03/31/2004 | EP1403247A1 N-Alkanoylphenylalanine derivatives |
| 03/31/2004 | EP1402899A1 Remedies for sepsis |
| 03/31/2004 | EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors |
| 03/31/2004 | EP1401918A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/31/2004 | EP1401824A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 03/31/2004 | EP1401821A1 Novel phenylalkyl diamine and amide analogs |
| 03/31/2004 | EP1015421B1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 03/31/2004 | CN1486313A Compounds for use in the treatment of skin conditions |
| 03/31/2004 | CN1486297A Primary intermediates for oxidative coloration of hair |
| 03/31/2004 | CN1143854C Novel 2-(iminomethyl) amino-phenyl derivatives,the preparation thereof, application as medicines and pharmaceutical compositions containing same |
| 03/30/2004 | US6713651 β2-adrenergic receptor agonists |
| 03/30/2004 | US6713464 Derivatives of 3,3-diphenylpropylamines |
| 03/30/2004 | CA2278687C 5-aroylnaphthalene derivatives |
| 03/25/2004 | WO2004024991A1 Organic salts and their use as reagents in electrochemical reactions |
| 03/25/2004 | WO2004024878A2 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 03/25/2004 | WO2004024703A1 Process for the preparation of 4- (3’-chloro-4’-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline |
| 03/25/2004 | WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 03/25/2004 | WO2004024677A1 N-hydroxyformamidine derivative |
| 03/25/2004 | WO2003104167A3 Cyanohydrin ethers and esters as high-sensitivity enzyme substrates |
| 03/25/2004 | WO2003084941A3 Hydroxamic acid derivatives |
| 03/25/2004 | WO2003082260A3 Tuberculosis treatment using pleuromutilin derivatives |
| 03/25/2004 | WO2003004480A3 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 03/25/2004 | US20040059134 Introducing in a reactor a5-amino-3-(carboxyalkyl)-4-cyano-2-thiophenecarboxylic acid, potassium carbonate and a quaternaryammonium salt as catalyst acetone solvent and methyl bromo acetate, heating and cooling |
| 03/25/2004 | US20040059109 Alanine 2, 6-dialkoxyphenyl ester derivatives as hypnotics |
| 03/25/2004 | US20040059004 10-aryl-11h-benzo[b]fluorene derivatives and analogs for medicinal use |
| 03/25/2004 | US20040058933 Aryl carbamate derivatives, preperation and use thereof |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058916 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 03/25/2004 | US20040058913 Cyclic diamine compound with condensed-ring groups |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | CA2498936A1 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 03/25/2004 | CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
| 03/24/2004 | EP1400510A1 Cyclic diamine compounds having fused-ring groups |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399417A1 Method for producing perfluoroalkanesulfonic acid esters |
| 03/24/2004 | EP1399414A2 Substituted tetracycline compounds for the treatment of malaria |
| 03/24/2004 | EP1399159A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2004 | EP1399146A1 Novel compounds and compositions as cathepsin inhibitors |
| 03/24/2004 | EP1292599B1 Solutions of lithium pyrrolidine in tetrahydrofuran (thf)/hydrocarbons |
| 03/24/2004 | EP1214296B1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/24/2004 | EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/24/2004 | CN1484633A N (phenylsulphonyl) glycine derivatives and their therapentic use |
| 03/24/2004 | CN1142910C Amide compounds |
| 03/23/2004 | US6710200 Using reporter molecule derivative having aldehyde or ketone group detectable by fluorescence emission, ultraviolet radiation, absorptivity or colorimetric analysis; rearrangements |
| 03/23/2004 | US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 03/23/2004 | US6710057 Inhibitors of factor xa, as anticoagulants for prophylaxis and treatment of thromboembolic disorders |
| 03/23/2004 | US6710043 Possess the potentiation of the cholinergic activity |
| 03/23/2004 | CA2168432C Piperazine compounds used in therapy |
| 03/18/2004 | WO2004022548A1 Process for producing oxycarbonyl-substituted piperazine derivative |
| 03/18/2004 | WO2004022534A1 Arylglycine derivatives for use as glycine transport inhibitors |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022528A2 Arylglycine derivatives and their use as glycine transport inhibitors |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2003102202A3 Process for preparing vinylaromatic compounds |
| 03/18/2004 | WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/18/2004 | WO2003097576A3 Diamino-functional chalcones |
| 03/18/2004 | WO2003018535A3 Novel aminobenzoephenones |
| 03/18/2004 | US20040054178 Labels for chromatography, spectroscopes |
| 03/18/2004 | US20040054172 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids |
| 03/18/2004 | US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders |
| 03/18/2004 | US20040053983 1, 2, 4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
| 03/18/2004 | US20040053953 Treatment of chemokine mediated diseases |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053925 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 03/18/2004 | US20040053916 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 03/18/2004 | US20040053907 Cell adhesion inhibitors |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | US20040053826 Uses of polypeptides |
| 03/18/2004 | US20040053786 Insecticidal 1,8-naphthalenedicarboxamides |
| 03/18/2004 | US20040053330 Amino polyols and amino sugars |
| 03/18/2004 | US20040052828 Provide a cooling sensation to a consumer, which cooling component includes cyclopenten-1-one-2-enamine derivative |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | CA2495939A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers |
| 03/17/2004 | EP1398030A2 Dipeptidyl peptidase IV effectors |
| 03/17/2004 | EP1397382A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 03/17/2004 | EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/17/2004 | EP1252151B1 A process for the preparation of quetiapine and intermediates therefor |
| 03/17/2004 | EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion |
| 03/17/2004 | EP1140839B1 Heterocyclic amides as inhibitors of factor xa |
| 03/17/2004 | EP1140810B1 Benzenic sulphonamide derivatives and their uses |
| 03/17/2004 | EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 03/17/2004 | CN1483030A Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders |